Gautam Sarma

Gautam Sarma

Active Director Director DIN 07997684
DIN 07997684 First appointment Dec 2017 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 13 active board seats
Past companies 1 historical roles
Total affiliations 14 Since Dec 2017
Shareholding value β€’β€’β€’β€’ Premium profile
Directorship timeline
First appointment 05 Dec 2017
Active appointments 13
Total timeline records 14

Gautam Sarma (DIN 07997684) has 14 recorded board appointments in Indian companies, the first from December 2017, of which 13 are current. The chart and the list below show each company, the role held and the years of the appointment, as filed with the Ministry of Corporate Affairs.

Appointment history

Since 2017
Aurelius G Hospital Private Limited Director · 2025 – present
Current
Aurelius North India Private Limited Director · 2025 – present
Current
Aurelius India Private Limited Additional Director · 2024 – present
Current
Current
Aurelius South India Private Limited Additional Director · 2023 – present
Current
Stalhmarg India Private Limited Additional Director · 2022 – present
Current
Ayursundra Diagnostics Private Limited Director · 2021 – present
Current
Ayursundra Hospitals(Jorhat) Private Limited Additional Director · 2019 – present
Current
Ayursundra Oncology (India) Private Limited Additional Director · 2019 – present
Current
Prometheus Advisory And Services Private Limited Additional Director · 2019 – present
Current
Ayursundra Oncology (Guwahati) Private Limited Additional Director · 2019 – present
Current
Ziksana Education (India) Private Limited Additional Director · 2018 – present
Current
Concretion Lab Solutions Llp Designated Partner · 2017 – present
Current
Previous

Interactive timeline

Hover bars for tenure details
Loading chart...
Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available